Alzheimer's disease

Sage continues downslide as Alzheimer’s study fails
BioPharma Dive
Tue, 10/8/24 - 10:00 pm
SAGE Therapeutics
Alzheimer's disease
clinical trials
SAGE-718
Sage scraps Alzheimer's program as dalzanemdor goes 0 for 2, leaving hopes resting on Huntington's
Fierce Biotech
Tue, 10/8/24 - 09:53 am
SAGE Therapeutics
Alzheimer's disease
dalzanemdor
clinical trials
An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped?
Pharma Voice
Fri, 10/4/24 - 09:19 am
Cassava Sciences
Alzheimer's disease
data manipulation
Cassava, former execs ink SEC deal to resolve allegations around misleading Alzheimer's data drop
Fierce Biotech
Mon, 09/30/24 - 09:23 am
Cassava Sciences
Alzheimer's disease
SEC
Eli Lilly's Alzheimer's drug approved in Japan
Reuters
Tue, 09/24/24 - 11:39 am
Eli Lilly
Japan
donanemab
Alzheimer's disease
Their Alzheimer’s treatment worked — but shares fell anyway
Pharma Voice
Thu, 08/29/24 - 11:06 am
Cognition Therapeutics
clinical trials
Alzheimer's disease
CT1812
Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment
Pharmaphorum
Mon, 08/26/24 - 10:14 am
Alzheimer's disease
physicians
Eli Lilly
Kisunla
donanemab
lecanemab
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thu, 08/22/24 - 11:45 am
Eisai
Biogen
Leqembi
UK
Alzheimer's disease
Australian biotech's cortisol blocker fails to improve attention in phase 2 depression study
Fierce Biotech
Mon, 08/12/24 - 11:31 am
Actinogen
cortisol blockers
depression
Alzheimer's disease
clinical trials
Lilly's tau drug for Alzheimer's flunks phase 2 test
Pharmaphorum
Fri, 08/9/24 - 11:18 am
Eli Lilly
Alzheimer's disease
clinical trials
LY3372689
Vaccinex’s Phase Ib/II trial for Alzheimer’s treatment hits primary endpoint
Clinical Trials Arena
Wed, 07/31/24 - 11:14 pm
Vaccinex
clinical trials
Alzheimer's disease
pepinemabin
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial
BioSpace
Tue, 07/30/24 - 11:48 am
Novo Nordisk
liraglutide
clinical trials
Alzheimer's disease
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tue, 07/30/24 - 11:37 am
Eisai
EMA
Europe
Leqembi
Biogen
Alzheimer's disease
FDA approves Alpha Cognition's Zunveyl for mild-to-moderate Alzheimer disease
Neurology Live
Mon, 07/29/24 - 10:58 am
Alpha Cognition
FDA
Zunveyl
ALPHA-1062
Alzheimer's disease
Blood tests may have an edge spotting Alzheimer's
Axios
Mon, 07/29/24 - 10:46 am
Medtech
diagnostics
Alzheimer's disease
AbbVie axes midstage Alzheimer's program amid 'evolving landscape'
Fierce Biotech
Thu, 07/25/24 - 11:30 am
AbbVie
Alzheimer's disease
ABBV-916
Cassava Execs Step Down Amid DOJ Probe of Possible Alzheimer’s Drug Fraud
BioSpace
Thu, 07/18/24 - 11:07 am
Cassava Sciences
DOJ
fraud
Alzheimer's disease
simufilam
Novo leads $100m financing for Alzheimer's player Asceneuron
Pharmaphorum
Tue, 07/16/24 - 11:56 am
Novo Holdings
Asceneuron
funding
Alzheimer's disease
5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart

Pages